Rezolute presents expanded Phase 3 data for hyperinsulinism drug

Cevap yazmak için giriş yap yada kayıt ol.
Benzer konular Forum Tarih
A Sutro presents preclinical data on ADC pipeline at AACR meeting Hisse Senetleri 0 4
A Monopar presents Phase 3 Wilson disease trial data at AAN meeting Hisse Senetleri 0 4
A Xenon presents positive epilepsy drug trial data at AAN meeting Hisse Senetleri 0 4
A Whitehawk presents preclinical data on three ADC candidates at AACR Hisse Senetleri 0 5
A Pliant presents updated cancer trial data at AACR meeting Hisse Senetleri 0 3
A Nuvalent presents zidesamtinib data in pre-treated lung cancer Hisse Senetleri 0 6
A Rezolute CFO Evans Daron buys $28,500 in RZLT stock Hisse Senetleri 0 7
A Rezolute stock price target cut to $5 from $17 at BTIG after trial failure Hisse Senetleri 0 25

Benzer konular

Üst